A recently published study points to a novel mechanism for CaMKII activation during hyperglycemia and diabetes through the addition of an O-linked N-acetylglucosamine (O-GlcNAc) modification (Erickson et al., 2013). The gene discussed is CAMK2G; the disease is Hyperglycemia.